Position
Squarepoint Ops LLC in Monte Rosa Therapeutics, Inc.
Back to the book · All holders of GLUE
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $7.72K$15.68 → $16.45
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 10K | $157.3K | — | — | — | 0.0% |
| Q1 2026 | 37.1K | $610.4K | $16.45 | $7.72K | $445.4K | 0.0% |